Search the web
Welcome, Guest
[Sign Out, My Account]
EDGAR_Online

Quotes & Info
Enter Symbol(s):
e.g. YHOO, ^DJI
Symbol Lookup | Financial Search
LLTP > SEC Filings for LLTP > Form 8-K on 24-Sep-2013All Recent SEC Filings

Show all filings for LIGHTLAKE THERAPEUTICS INC. | Request a Trial to NEW EDGAR Online Pro

Form 8-K for LIGHTLAKE THERAPEUTICS INC.


24-Sep-2013

Other Events, Financial Statements and Exhibits


Item 8.01 Other Events.

On September 24, 2013, Lightlake Therapeutics Inc. (the "Company") issued a press release announcing that the Company has begun a two-week clinical trial designed to evaluate the pharmacokinetic properties of the Company's intranasal naloxone application in 14 healthy volunteer subjects. The trial began on September 23, 2013, and is being conducted in partnership with the National Institute on Drug Abuse, part of the National Institutes of Health. The press release describes the goal of the collaboration to establish a regulatory pathway for its opioid addiction treatment. A copy of the press release is filed as Exhibit 99.1 to this Current Report on Form 8-K.



Item 9.01 Financial Statements and Exhibits

(d) Exhibits

Exhibit No. Description
99.1 Lightlake Therapeutics Commences Two-Week Patient Trial for Treatment of Opioid Overdose with National Institute on Drug Abuse (NIDA) dated September 24, 2013.

  Add LLTP to Portfolio     Set Alert         Email to a Friend  
Get SEC Filings for Another Symbol: Symbol Lookup
Quotes & Info for LLTP - All Recent SEC Filings
Sign Up for a Free Trial to the NEW EDGAR Online Pro
Detailed SEC, Financial, Ownership and Offering Data on over 12,000 U.S. Public Companies.
Actionable and easy-to-use with searching, alerting, downloading and more.
Request a Trial      Sign Up Now


Copyright © 2014 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
SEC Filing data and information provided by EDGAR Online, Inc. (1-800-416-6651). All information provided "as is" for informational purposes only, not intended for trading purposes or advice. Neither Yahoo! nor any of independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. By accessing the Yahoo! site, you agree not to redistribute the information found therein.